# Deepvessel

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/deepvessel

- Industry: Healthcare IT
- Headquarters: Beijing, China
- Website: www.keyamedical.cn
- Total disclosed funding: $112M
- Latest round: Series D (Dec 31, 2020)
- Investors on record: 13

## About

Established in 2016 and based in Beijing, China, Deepvessel is a medical technology company that provides accurate analysis services for patient data via big data and AI. The company also has triple certifications of China NMPA, US FDA, and EU CE, and in August 2021, it established the Anzhen-Koya Artificial Intelligence Joint Laboratory. With a team of nearly 300 people, the company has entered into partnerships with nearly 120 hospitals within China and co-established more than 70 centers in 2020. In December 2020, the company closed a round of series D funding.

The Company mainly develops AI medical technology products, specifically DeepVessel FFR, DeepVessel AngioFFR, DeepVessel Cardisight, etc., which all utilize deep learning technology, as well as coronary computed tomography angiography imaging, multi-view X-ray angiography, etc., respectively, to assess the physiological function of Coronary arteries are evaluated for physiological function, and the results are represented in the form of 3D reconstruction and other forms.

## Funding rounds

- Series D, Dec 31, 2020, $46M — In Capital, Shanghai CCI Investment, Shanghai Artificial Intelligence Industry Investment Fund, Qianhai Gaozu capital
- Series C, Nov 10, 2020, $30M — IDG Capital, Source Code Capital, Alwin Capital, Tasly Holding Group
- Series B, Aug 13, 2020, $22M — Kunlun Fund, Alwin Capital, Shanghai Growth Investment, Jiyuan Capital
- Series B, Jul 9, 2020 — Kunlun Fund, Ambrum Capital
- Series B, Feb 20, 2020, $14M — IDG Capital, Kunlun Fund, Alwin Capital, Shanghai Growth Investment
- Series A, Apr 18, 2019 — Kunlun Fund, GX Capital

## Investors

- Kunlun Fund (https://capitalatlas.ai/funds/kunlun-fund) — Series A, Series B
- GX Capital (https://capitalatlas.ai/funds/gx-capital) — Series A
- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series B, Series C
- Alwin Capital — Series B, Series C
- Shanghai Growth Investment (https://capitalatlas.ai/funds/shanghai-growth-investment) — Series B
- Ambrum Capital (https://capitalatlas.ai/funds/ambrum-capital) — Series B
- Jiyuan Capital (https://capitalatlas.ai/funds/jiyuan-capital) — Series B
- Source Code Capital (https://capitalatlas.ai/funds/source-code-capital) — Series C
- Tasly Holding Group — Series C
- In Capital — Series D
- Shanghai CCI Investment — Series D
- Shanghai Artificial Intelligence Industry Investment Fund — Series D
- Qianhai Gaozu capital — Series D